#218: Reimagining Pharma Supply Chains for Growth and Patient Impact with Arun Krishnan of AstraZ...

Why It Matters

AstraZeneca’s AI‑driven, self‑healing supply chain will boost resilience and speed, directly improving patient access and positioning the firm ahead of competitors in a volatile global market.

Key Takeaways

• AstraZeneca aims $80B revenue by 2030 through supply chain overhaul.
• AI-driven “self‑healing” supply chain shifts work from humans to machines.
• Three‑pillars strategy: product innovation, AI‑enabled processes, workforce upskilling.
• Emphasis on “supply first” principle ensures on‑time, full patient deliveries.
• Digital twins and risk‑sensing improve agility amid geopolitical volatility.

Summary

In this Leaders in Supply Chain podcast, AstraZeneca’s SVP of Global Supply Chain and Strategy, Arun Krishnan, outlines the company’s ambitious drive to become an $80 billion enterprise by 2030. The discussion centers on a comprehensive re‑imagining of the pharma supply chain, integrating new modalities such as cell therapy, AI‑powered operations, and a workforce transformation agenda. Krishnan describes three interlocking dimensions: product and market growth, AI‑enabled process redesign, and people empowerment through reskilling. He stresses a "supply first" mantra, asserting that on‑time, full‑volume delivery to patients is non‑negotiable, while also leveraging the "power of and"—combining supply reliability with efficiency and productivity. Concrete examples include a self‑healing supply chain where AI agents generate weekend analytics and recommendations, digital twins that simulate the entire network to cut waste, and AI‑driven risk‑sensing that accelerates response to disruptions. Krishnan highlights the AI30 mandate—30 % smarter, faster, and more precise—as a catalyst for continuous employee upskilling. The initiative promises faster, more resilient drug deliveries, reduced variability, and a competitive edge for AstraZeneca. By turning the supply chain into a decision‑stack intelligence platform, the company aims to safeguard patient access while supporting its broader growth and innovation objectives.

Original Description

Arun Krishnan, SVP of Global Supply Chain and Strategy at AstraZeneca, shares how the company is reimagining its supply chain to support ambitious growth while keeping patients at the center. He discusses AstraZeneca’s focus on innovation, AI-enabled ways of working, self-healing supply chains, and the importance of building capabilities for the future. Arun also explains how the organization continues to maintain strong global supply delivery amid volatility, from the pandemic to geopolitical disruption. Throughout the conversation, he emphasizes the role of curiosity, continuous learning, and empowered leadership in helping people and supply chains adapt to a rapidly changing world.

Discover more details here (https://alcottglobal.com/podcast/leaders-in-supply-and-chain-logistics-podcast/218-reimagining-pharma-supply-chains-for-growth-and-patient-impact-with-arun-krishnan-of-astrazeneca/) .

Follow us on:

Instagram: http://bit.ly/2Wba8v7

LinkedIn: https://bit.ly/4hbidqo

Facebook: http://bit.ly/2HtryLd